Interaction between cannabidiol (CBD) and Δ9- tetrahydrocannabinol (THC): Influence of administration interval and dose ratio between the cannabinoids

Psychopharmacology

Volumn 219, Issue 1, 2012, Pages 247-249

  Zuardi, Antonio Waldo ^a,b   Hallak, Jaime Eduardo Cecílio ^a,b   Crippa, José Alexandre S ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute for Translational Medicine (INCT TM CNPq)   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; CORTICOSTERONE; DRONABINOL;

ACUTE DRUG ADMINISTRATION; ANXIETY; BEHAVIOR CHANGE; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG ELIMINATION; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; INTERMETHOD COMPARISON; LETTER; MAZE TEST; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; CANNABIDIOL; MALE; TETRAHYDROCANNABINOL;

EID: 84856682209     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2495-x     Document Type: Letter

References (18)

1. S Bhattacharyya PD Morrison P Fusar-Poli R Martin-Santos S Borgwardt T Winton-Brown C Nosarti CM O' Carroll M Seal P Allen MA Mehta JM Stone N Tunstall V Giampietro S Kapur RM Murray AW Zuardi JA Crippa Z Atakan PK McGuire 2010 Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology Neuropsychopharmacology 35 764 774 10.1038/npp.2009.184 19924114 10.1038/npp.2009.184 1:CAS:528: DC%2BC3cXhtlCrur0%3D
2. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt SJ, Fusar-Poli P, Rubia K, Kambweitz J, O'Carroll C, Seal ML, Giampietro V, Brammer M, Zuardi AW, Atakan Z, McGuire PK (2011) Delta 9-tetrahydrocannabinol modulates hippocampal and striatal function during oddball salience processing. Arch Gen Psychiatr (in press)
3. Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, Woodcock H, Dorward P, Pigliacampo B, Close S, Platt B, Riedel G (2011) Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl). doi: 10.1007/s00213-011-2415-0
4. P Fusar-Poli JA Crippa S Bhattacharyya SJ Borgwardt P Allen R Martin-Santos M Seal SA Surguladze C O'Carrol Z Atakan AW Zuardi PK McGuire 2009 Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing Arch Gen Psychiatr 66 95 105 19124693 10.1001/archgenpsychiatry.2008.519 1:CAS:528:DC%2BD1MXhslSrur8%3D
5. FS Guimaraes TM Chiaretti FG Graeff AW Zuardi 1990 Antianxiety effect of cannabidiol in the elevated plus-maze Psychopharmacology (Berl) 100 558 559 10.1007/BF02244012 1:CAS:528:DyaK3cXhvFWrsb0%3D (Pubitemid 20102368)
6. G Jones RG Pertwee 1972 A metabolic interaction in vivo between cannabidiol and 1-tetrahydrocannabinol Br J Pharmacol 45 375 377 5048656 1:STN:280:DyaE383ksV2msg%3D%3D
7. EL Karschner WD Darwin RS Goodwin S Wright MA Huestis 2011 Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration Clin Chem 57 66 75 10.1373/clinchem.2010.152439 21078841 10.1373/clinchem.2010.152439 1:CAS:528:DC%2BC3MXitFSlu7k%3D
8. EL Karschner WD Darwin RP McMahon F Liu S Wright RS Goodwin MA Huestis 2011 Subjective and physiological effects after controlled Sativex and oral THC administration Clin Pharmacol Ther 89 400 407 10.1038/clpt.2010.318 21289620 10.1038/clpt.2010.318 1:CAS:528:DC%2BC3MXhvFKnsLw%3D
9. Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS (2011) Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology (Berl). doi: 10.1007/s002-011-2342-0
10. WD Paton RG Pertwee 1972 Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism Br J Pharmacol 44 250 261 4668592 1:CAS:528:DyaE38XktVSlsbw%3D
11. MJ Reid LM Bornheim 2001 Cannabinoid-induced alterations in brain disposition of drugs of abuse Biochem Pharmacol 61 1357 1367 11331071 10.1016/S0006-2952(01)00616-5 1:CAS:528:DC%2BD3MXivFegurg%3D (Pubitemid 32452351)
12. TT Winton-Brown P Allen S Bhattacharrya SJ Borgwardt P Fusar-Poli JA Crippa ML Seal R Martin-Santos D Ffytche AW Zuardi Z Atakan PK McGuire 2011 Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study Neuropsychopharmacology 36 1340 1348 10.1038/npp.2011.17 21412224 10.1038/npp.2011.17 1:CAS:528:DC%2BC3MXmtVOqtLY%3D
13. AW Zuardi 2008 Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action Rev Bras Psiquiatr 30 271 280 18833429 10.1590/S1516-44462008000300015
14. AW Zuardi IG Karniol 1983 Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination Braz J Med Biol Res 16 2 141 146 6317104 1:CAS:528: DyaL3sXlvVOmsro%3D (Pubitemid 13012870)
15. AW Zuardi IG Karniol 1984 Pharmacological interaction between 9-tetrahydrocannabinol and cannabidiol, two active constituents of Cannabis sativa Ciência e Cultura 36 6 386 394 1:CAS:528:DyaL2cXktVSjsrc%3D
16. AW Zuardi E Finkelfarb OF Bueno RE Musty IG Karniol 1981 Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol Arch Int Pharmacodyn Ther 249 137 146 6261703 1:CAS:528:DyaL3MXktVSmtrk%3D (Pubitemid 11145549)
17. AW Zuardi I Shirakawa E Finkelfarb IG Karniol 1982 Action of cannabidiol on the anxiety and other effects produced by delta9-THC in normal subjects Psychopharmacology (Berl) 76 245 250 10.1007/BF00432554 1:CAS:528: DyaL38XktFKlu74%3D (Pubitemid 12129400)
18. AW Zuardi NA Teixeira IC Karniol 1984 Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats Arch Int Pharmacodyn Ther 269 1 12 19 6087750 1:CAS:528:DyaL2cXktlarsbk%3D (Pubitemid 14113549)